Our major areas of interest are:

Valsalakumari R, Feith M, Pettersen S, Åslund AKO, Mørch Ý, Skotland T, Sandvig K, Mælandsmo GM, Iversen TG (2025)
Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells
Pharmaceutics, 17 (5)
DOI 10.3390/pharmaceutics17050657, PubMed 40430947

Torices L, Nunes-Xavier CE, Pulido R (2025)
Therapeutic Potential of Translational Readthrough at Disease-Associated Premature Termination Codons From Tumor Suppressor Genes
IUBMB Life, 77 (5), e70018
DOI 10.1002/iub.70018, PubMed 40317855

Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A (2025)
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases
Ther Adv Med Oncol, 17, 17588359251332473
DOI 10.1177/17588359251332473, PubMed 40297622